BridgeBio Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
BridgeBio General Information
Description
Developer of biopharmaceutical products intended for biopharmaceutical partners engaged in bispecific and multispecific antibodies. The company is engaged in the research and development of bispecific antibodies, multi-specific antibodies, and antibody-drug conjugates, thereby enabling clients to generate bispecific and multi-specific therapeutic candidates.
Contact Information
Corporate Office
- Room 6228, 2nd Floor, Building 6
- Number 688 Kangqiao East Road, China (China) Pilot Free Trade Zone
- Shanghai, 201203
- China
Corporate Office
- Room 6228, 2nd Floor, Building 6
- Number 688 Kangqiao East Road, China (China) Pilot Free Trade Zone
- Shanghai, 201203
- China
BridgeBio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BridgeBio FAQs
-
When was BridgeBio founded?
BridgeBio was founded in 2017.
-
Where is BridgeBio headquartered?
BridgeBio is headquartered in Shanghai, China.
-
What industry is BridgeBio in?
BridgeBio’s primary industry is Biotechnology.
-
Is BridgeBio a private or public company?
BridgeBio is a Private company.
-
What is the current valuation of BridgeBio?
The current valuation of BridgeBio is .
-
What is BridgeBio’s current revenue?
The current revenue for BridgeBio is .
-
When was BridgeBio acquired?
BridgeBio was acquired on 28-Oct-2025.
-
Who acquired BridgeBio?
BridgeBio was acquired by NovaBridge Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process